NCT03635606View on ClinicalTrials.gov

GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients

CompletedOBSERVATIONAL
Enrollment

370

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

September 1, 2022

Study Completion Date

February 28, 2023

Conditions
Coronary Artery Disease
Trial Locations (3)

21287

Johns Hopkins University, Baltimore

27610

WakeMed Health and Hospitals, Raleigh

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors

Lead Sponsor

Sapere Bio
All Listed Sponsors
collaborator

WakeMed Health and Hospitals

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Hoag Memorial Hospital Presbyterian

OTHER

lead

Sapere Bio

INDUSTRY

NCT03635606 - GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter